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5610 | Analyst, 2013, 138, 5610–561Toward optimal spatial and spectral quality in widefield
infrared spectromicroscopy of IR labelled single cells
Eric C. Mattson,†a Miriam Unger,†‡a Sylvain Cle`de,bcd François Lambert,bcd
Clotilde Policar,bcd Asher Imtiaz,e Roshan D'Souzae and Carol J. Hirschmugl*a
Advancements in widefield infrared spectromicroscopy have recently been demonstrated following the
commissioning of IRENI (InfraRed ENvironmental Imaging), a Fourier Transform infrared (FTIR) chemical
imaging beamline at the Synchrotron Radiation Center. The present study demonstrates the effects of
magnification, spatial oversampling, spectral pre-processing and deconvolution, focusing on the
intracellular detection and distribution of an exogenous metal tris-carbonyl derivative 1 in a single
MDA-MB-231 breast cancer cell. We demonstrate here that spatial oversampling for synchrotron-based
infrared imaging is critical to obtain accurate diffraction-limited images at all wavelengths
simultaneously. Resolution criteria and results from raw and deconvoluted images for two Schwarzschild
objectives (36, NA 0.5 and 74, NA 0.65) are compared to each other and to prior reports for raster-
scanned, confocal microscopes. The resolution of the imaging data can be improved by deconvolving
the instrumental broadening that is determined with the measured PSFs, which is implemented with
GPU programming architecture for fast hyperspectral processing. High definition, rapidly acquired, FTIR
chemical images of respective spectral signatures of the cell and 1 shows that 1 is localized next to the
phosphate- and Amide-rich regions, in agreement with previous infrared and luminescence studies. The
infrared image contrast, localization and definition are improved after applying proven spectral pre-
processing (principal component analysis based noise reduction and RMie scattering correction
algorithms) to individual pixel spectra in the hyperspectral cube.1 Introduction
Wideeld Fourier Transform infrared (FTIR) spectromicroscopy
is emerging as an invaluable tool for performing chemically-
specic microscopy in a variety of disciplines ranging from
biology and medicine1–5 to materials science.6,7 Wideeld
synchrotron-based FTIR spectromicroscopy, combining high
density spatial and high signal-to-noise broadband spectral
information, has recently been developed at the Synchrotron
Radiation Center in Madison, WI.8,9 There are two main
components of the beamline dedicated to this experimental
technique that distinguish it from previous synchrotron based
Infrared beamlines equipped with FTIR microspectrometers.10–16ilwaukee, Milwaukee, WI, USA. E-mail:
chimie, 24, rue Lhomond, 75005 Paris,
Place Jussieu, 75005 Paris, France
f Wisconsin-Milwaukee, Milwaukee, WI,
chnologies GmbH, D 73728 Esslingen
8The rst unique component of the beamline is the large swath of
radiation that has been collected, divided and recombined to
create a homogeneous wideeld illumination at the sample plane
in the microscope. The extended area that is illuminated is
approximately 40  40 micrometers2 for the central, homoge-
neously, illuminated section, but can also illuminate up to
140  140 micrometers2 with reduced signal levels in the outer
most areas of the eld of view. The second component of the
beamline that is critical is a multi-element detector, which is
employed to collect multiple spectra simultaneously, retaining
spatial denition. Both of these attributes are critical compo-
nents to achieve rapid IR imaging with high spatial denition.
In general FTIR spectroscopy is an attractive technique for bio-
imaging, as excitations in the IR do not induce photo-bleaching
contrary to what is observed with organic uorophores in the
visible or UV-range.17 Interestingly, IR specic biomarkers such
as metal-carbonyl derivatives show an intense absorption in the
IR transparency window of biological media in the 1850–2200
wavenumber region18 and have already been used as IR-
labels.17,19–22 Moreover, they are relevant tools for biological
studies since they are stable in biological environment and cause
few steric disturbances because of their small size. The rhenium
tris-carbonyl derivative 1 (Scheme 1), synthesized and studied as
previously described,19 has two carbonyl absorption bands atThis journal is ª The Royal Society of Chemistry 2013
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View Article Online1915 cm1 (E-band, asymmetric stretching, doubly degenerate)
and at 2025 cm1 (A1-band, symmetric stretching). Absorption at
2100 cm1 is attributed to the azide moiety. Here, wideeld
synchrotron-based FTIR spectromicroscopy provides high spatial
denition and rapid detection of 1 at a single cell level, inside
breast cancer cells (MDA-MB-231) incubated in the micro-molar
range (25 mM, 1 h, 37 C). The resulting chemical images show
clear detection and localization of the biomarker and cellular
components.
Spectrochemical images collected in the conguration
employed at IRENI are diffraction limited. Diffraction-limited
imaging is dependent on the wavelength of the probe light and
on the NA of the objectives. The common Rayleigh criterion,
which describes the ability of an imaging system to resolve two
neighbouring point sources, is dened as d ¼ 0.61l/NA, where d
is theminimum separation required to resolve the points, l is the
probing wavelength, and NA is the numerical aperture of the
imaging system. At this minimum separation, the contrast
between two point sources is equal to 26.4%, and this contrast
criterion is used in practice as a criterion to determine whether
two objects are considered resolved according to the Rayleigh
law. In the present case, Schwarzschild objectives are employed,
leading to a different description that is not available in closed
form, but a similar contrast criterion can be employed. Mid-
infrared spectra are broadband; the wavelengths range from 2 to
10 mm, and thus it is impossible to collect high denition data
for all wavelengths simultaneously if one uses only apertures and
a single point detector. One must compromise either signal or
spatial denition. Spatial oversampling is one strategy to obtain
diffraction-limited, spatially resolved images across this band-
width. The contrast resolution for confocal, dual aperture
systems is predicted to be superior to one aperture systems, since
the point spread function (PSF) is a multiplicative effect of two
Schwarzschild objective PSFs, resulting in a narrower central
peak and suppressed sidelobes at each wavelength.23 Reports of
the contrast resolution determined from sufficiently spatially
oversampled, raster-scanned data for confocal microscope optics
with no apertures illuminated with a synchrotron beam were
similar11,24 to the predicted values with dual apertures. For the
wideeld geometry employed in the present experiment, which is
also apertureless, the pixel size, and thus spatial oversampling is
based on the magnication of the objective that projects a
certain area of the sample onto the detector pixels. Here the
combination of spatial oversampling and NA inuences the
resolution of synchrotron-based wideeld imaging. ResultsScheme 1 Chemical structure of the derivative, named 1.
This journal is ª The Royal Society of Chemistry 2013employing an array detector will be compared to results in the
literature11,23,24 for synchrotron-based confocal, dual aperture,
raster-scanning systems. We show that they are, within experi-
mental noise, identical for deconvoluted image data and raster-
scanned data from the confocal microscope, which is signicant
since samples are measured more quickly with the array
detector. Analysis of spectrochemical images acquired from test
samples and breast cancer cells using two distinct optical
throughputs will be compared. In particular, two Schwarzschild
objectives with varying magnication and NA (36, 0.5 NA and
74, 0.65 NA), both used in the Bruker Hyperion 3000 micro-
scope, will be used to demonstrate this. While the highest
magnication is likely desirable in most cases, experimental
constraints sometimes require the inherently larger working
distance (i.e. environmental controlled stages) and or the lower
numerical aperture (i.e. tomography25) that are available with the
lower magnication and lower NA objective. The comparison
between the different magnications and NAs allows an exami-
nation of the impact of spatial oversampling on the contrast
resolution for both test samples and single breast cancer cells.
Chemical images obtained from hyperspectral cubes can be
impacted by the quality of both the spatial and spectral infor-
mation. Measurements of FTIR spectra of tissues and cells in
transmission mode oen produce spectra with inherent base-
line effects and derivative shapes as a result of resonant Mie
scattering. The scattering effect is particularly strong near edges
of the cell or when features with a high contrast in refractive
index are approximately the same size as the wavelength of the
irradiating light. As a consequence, to provide a more quanti-
tative analysis of effected cells, a resonant Mie scattering
correction algorithm can be employed to removed these scat-
tering effects from each spectrum in the hyperspectral cube.26–29
In this article we demonstrate the impact of employing a noise
reduction algorithm based on a principal component analysis
(PCA) followed by resonant Mie scattering spectral corrections
and spatial deconvolution corrections to data for single cells.
These proven algorithms are useful, since the biomarker is used
in small concentrations and results in relatively weak absorp-
tion bands. The resulting data show both improved signal-
to-noise for single pixel spectra, and higher contrast in the
chemical images generated from the absorption features due to
the biomarker specic functional groups.2 Materials and methods
2.1 Sample preparation
MDA-MB-231 breast cancer cells obtained from the Human
Tumour Cell Bank were used for the experiments. Both control
and treated cells were processed in a similar way. They were
seeded on CaF2 slides (deposited in 35 10 mm Petri dishes) in
order to reach conuency aer 48 h of incubation at 37 C under
an atmosphere of 95% air/5% CO2. Medium was removed and
fresh growth medium (2 mL DMEM charcoal desteroided) was
added to each ask of control cells. In the case of treated cells,
2 mL of a solution of 1 in fresh growthmedium (25 mMprepared
from a 5  103 M stock solution in DMSO) were added. The
cells were incubated at 37 C under an atmosphere of 95%Analyst, 2013, 138, 5610–5618 | 5611
Fig. 1 Predicted and experimental spatial resolutions of original and deconvo-
luted data. Contrast resolution (solid lines) of the PSF for the 36 (NA 0.5) and
74 (NA 0.6NA) objectives compared to the experimentally determined resolu-
tion limit for the 36 (NA 0.5) and 74 (NA 0.6NA) objectives before (open
circles) and after (filled triangles) deconvolution, and with reported NA depen-
dent trends for confocal, raster scanning resolution limits (dotted lines).
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View Article Onlineair/5% CO2 for a period of 1 h. Themedia was then removed and
the cells were washed twice with phosphate buffered saline
(D-PBS, 1, 2 mL). Cells were xed by 4% paraformaldehyde
(1.5 mL) for 8 minutes at room temperature and washed once
with D-PBS (1, 2 mL) and once with pure water (2 mL). Slides
were then air-dried.
2.2 IRENI FTIR spectroscopic imaging measurements
For the present investigations, each FTIR hyperspectral cube
(x, y, A(n)) was recorded in transmission mode using one of
two optical setups: (1) a 74 objective (NA ¼ 0.65) and a
20 condenser (NA ¼ 0.65) or (2) a 36 objective (NA ¼ 0.5)
and a 15 condenser (NA ¼ 0.4). The size of the FPA detector
was set to 64  64 pixels, and 4096 individual spectra were
measured simultaneously. With the former setup the measured
area was 34  34 mm2 with an effective geometric pixel size
of 0.54  0.54 mm2, and the latter setup measured an area of
70 70 mm2with an effective geometric pixel size of 1.1 1.1 mm2.
Spectra were acquired with a spectral resolution of 4 cm1 and
128 scans. The measurement time for each sample was about
5 minutes. The resulting spectra and FTIR imaging data were
evaluated by using the IR imaging soware IRidys running under
IGOR Pro 6.22.
2.3 Spatial deconvolution applied to hyperspectral cubes
The deconvolution approach has been described in detail in a
recent publication.30 Fast parallel algorithms have been imple-
mented on graphics processing units (GPUs) for spatial
deconvolution using NVIDIA's CUDA. NVIDIA CUDA has a
library called CUFFT for efficiently computing discrete Fourier
Transform.31 The library provides an interface for computing
parallel fast Fourier transforms (FFTs), the most computation-
ally expensive component of the algorithm, on GPU.32 This
allows multiple transforms of any dimension to be executed in
parallel in batches. The hyperspectral deconvolution algorithm
involves the computation of FFTs three times for every wave-
length in the data set, so efficiently parallelizing FFTs was
signicant in achieving a higher speed up. We also used Thrust
library from NVIDIA to implement some other parts of the
algorithm. Efficient implementations of the generic parallel
reduction algorithms combined with transform iterators were
used in particular to perform image scaling33 in parallel. Our
GPU implementation achieved a speed up of 20 as compared
to the previous implementation of algorithm on centralized
processing unit (CPU) and Matlab. In brief, Fourier Transform
(FT) based image deconvolution methods have been developed
based on the measured and simulated PSFs, which have been
measured and are distinct for each optical setup. Each image is
deconvoluted independently and is subsequently rescaled by
requiring equal transmitted light in the original and processed
data. Finally, the data are reassembled in a hyperspectral cube.
2.4 Spectral pre-processing
Spectral pre-processing was performed using Matlab Version
2012a (MathWorks Inc, Palo Alto, CA). Noise reduction based on
PCA was applied to each hyperspectral dataset image to further5612 | Analyst, 2013, 138, 5610–5618improve the signal-to-noise ratio (SNR) for the individual spectra
in each pixel. The process involves performing PCA, retaining a
number of PCs and then reconstructing the original data from
the remaining PCs. The appropriate number of PCs (here, 20 PCs)
was chosen by examining the residual that is calculated from the
original data matrix minus the reconstructed matrix.34
Following PCA noise reduction, the RMieS algorithmwas used
to correct the data for resonant Mie (RMie) scattering effects.
Generally, the algorithm takes a scatter free reference spectrum
(Zref) (Matrigel, a commercial extra cellular matrix that contains
all components expected for tissues/cells; nothing was added to
theMatrigel standard to account for the biomarker) and uses this
to reconstruct the raw spectrum (Zraw) to be corrected. This is
done by assuming that Zraw is the superposition of Zref and a
number of scattering curves that are determined from the
broadband signal in each spectrum from the hyperspectral cube.
The impact of the mixing of the real and imaginary part of the
index of refraction due to the broadband Mie scattering effects is
taken into account. The mathematical background of RMie
scattering correction is described in detail elsewhere.26–283 Results and discussion
3.1 Spatial resolution of 36 (NA ¼ 0.5) and 74 (NA¼ 0.65)
objectives
In Fig. 1, we compare simulated resolutions based on the
parameters determined from the experimental PSFs30 for both
objectives with the experimentally-determined wavelength-
dependent resolution of both objectives. First, we evaluated the
experimentally measured PSFs to nd the PSF contrast resolu-
tion (PSFCR), which is similar to the Rayleigh criterion for the
Airy function, for the two objectives (solid lines, right axis). Two
objects are considered resolved if the contrast difference
between them exceeds 26.4%,35 so the full width at 73.6%
maximum is the PSFCR. The determined PSFCR is wavelengthThis journal is ª The Royal Society of Chemistry 2013
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View Article Onlinedependent, and smaller for the 74 than for the 36 objective,
particularly at the longest wavelengths. As expected, the NA of
the objectives is the dominating factor in the experimental
PSFCR, as described within the framework of the Rayleigh
criterion. We compare these results to experimentally resolved
USAF targets, both the original experimental (open circles) and
deconvoluted (solid triangles), as described elsewhere.8,9,30,36
The original data (0.54  0.54 mm2 projected sample area per
pixel) for the 74 magnication is only slightly above that
predicted by the simulated PSFCRs. In contrast, the original
data for the 36 show a poorer agreement with the predicted
PSFCR, likely due to the coarser spatial sampling (1.1  1.1 mm2
projected sample area per pixel), employed in this congura-
tion. In order to achieve optimal spatial resolution, the data
must be sampled with at least 8 pixels spanning the dimension
of the Airy disk for any given wavelength.35 Using the conven-
tional Rayleigh criterion for the shortest wavelength in the mid-
IR (2.5 mm), this corresponds to a pixel size no larger than
0.6 mm for the 74 objective, which is larger than the effective
pixel size in the geometry employed here. Conversely, this
sampling criterion for the 36 objective requires a pixel spacing
no larger than 0.76 mm, which is smaller than the effective pixel
size. Thus the optical setup for the 36 geometry is under-
sampled for wavelengths below 3.6 mm (2770 cm1).
Following deconvolution, however, both objectives yield reso-
lutions exceeding the predicted PSFCR criterion, yet still retain
their dependence on wavelength and NA as expected. This
suggests that instrumental broadening is successfully removed
through deconvolution, and a more faithful image is
recovered in both cases. Importantly, this resolution is similar
to and slightly exceeds that observed when using a confocal
dual-aperture, raster scanning microscope.11,17,18 In sum, with
the correct oversampling, and therefore projected sample pixel
size that is matched to the NA of the objective, one achieves
similar spatial resolution results for dual aperture confocal
geometries.Fig. 2 Visible and FTIR chemical images of MDA-MB-231 cells generated based on s
A1-band: 2013–2033 cm
1 and E-band: 1890–1932 cm1). (A) Top row: controlled cel
This journal is ª The Royal Society of Chemistry 20133.2 Chemical images of control and labelled cells
In order to determine the distribution of 1 in a MDA-MB-231
cell, chemical images collected with the 74 objective were
generated by integrating the area under individual absorption
bands that are distinctive for the single cell and 1. The following
integration parameters were used, (with straight baselines from
the integration endpoints) Amide I: 1680–1612 cm1, phos-
phate: 1260–1200 cm1, A1 mode of 1: 2033–2013 cm
1 and
E mode of 1: 1932–1890 cm1.19 The Amide I and phosphate
absorption bands are representative for the nucleus of the cell,37
while E- and A1-bands characterize the localization of 1. In
Fig. 2, the visible (VIS) images and the integrated intensity of the
Amide I, phosphate, E and A1 bands of a controlled and incu-
bated cell are displayed. The contour colors vary between red
(high intensity) to dark violet (low intensity), and the intensity
corresponds to the integrated band intensity. For better
comparison of the chemical images, constant scaling of the
contour colors has been applied as a visualization tool for each
individual functional group for displaying the differences of the
controlled and incubated cell. Based on the chemical images of
the cell incubated with 1 (Fig. 2B), it can be seen, that 1 is
heterogeneously distributed in the cell and co-localized in
regions of low Amide I and phosphate absorptions. Further-
more, to demonstrate the ability of IRENI to monitor variation
of the spectra from pixel to pixel, stacks of single pixel data,
spaced 2.2 micrometers apart from one another, along the
dashed lines in Fig. 2B of the cell incubated with 1 are depicted
in Fig. 3. In agreement with the integrated chemical images,
specic absorption bands of 1 are predominant in the central
region of the cell and are displaced slightly from the Amide-rich
nuclear region.37 The images presented here are consistent with
results previously described,19 since a perinuclear distribution
of 1 was observed using SR-FTIR raster scanning. In addition
imaging of cells labelled with both 1 and a uorescent Golgi
tracker inside MDA-MB-231 cells was performed, 1 being both
luminescent and infrared active.19pecific band integrations (Amide I: 1680–1612 cm1, phosphate: 1260–1200 cm1,
l, (B) bottom row: cell incubated with 1.
Analyst, 2013, 138, 5610–5618 | 5613
Fig. 3 Stacks of spectra taken from individual pixels along the dashed line in
Fig. 2B. The spectra come from pixels that are 2.2 mm apart. (A) shows the entire
midinfrared spectral region, while (B) focuses on the region in which the specific
bands of the biomarker can be found.
Fig. 4 Original and deconvoluted chemical images of a breast cancer cell
labelled with 1 takenwith both 74 and 36 objectives. (A) and (B) show original
chemical images (color scales: purple (low intensity) – red (high intensity)) of the
cell as measured with the 74 objective generated by integrating under A1 mode
of the biomarker (A), and Amide I (B). Scale bar in a is 20 mm. (C) and (D) show the
results of deconvolution of the data used to generate (A) and (B). (E) and (F) show
the analogous data of (A) and (B) as measuredwith the 36 objective. Scale bar in
(E) is 20 mm. (G) and (H) show the results of deconvolution of the data used to
generate (E) and (F).
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View Article Online3.3 Comparison of hyperspectral deconvolution of
spectrochemical datasets of labelled cells with 36 (NA ¼ 0.5)
and 74 (NA ¼ 0.65) objectives
In Fig. 4, we show integrated images of the protein specic
(Amide I) and metal carbonyl (A1) functional groups within a
second MDA-MB-231 incubated cell generated from both the
raw and deconvoluted data sets taken with the 36 and 74
objectives No spectral pre-processing has been applied in this
case. In the raw data taken with both objectives, the distribution
of the Amide shows a slight displacement from the localization
of the biomarker signature, which is discussed further below.
Upon comparison of the raw and deconvoluted data from both
objectives, it is clear that in all cases the deconvoluted images
show sharper, more well-dened features with enhanced
contrast.
To more qualitatively address the effect of deconvolution on
the data from both objectives, we compare intensity proles
through the same position of the cell for both datasets (Fig. 5).
The location of the prole used for the 74 data set is indicated
by the white line in Fig. 4A; all of the 74 proles in Fig. 5 from
the different functional groups are extracted from the exact
same location. The location from which the proles from the
36 data are extracted is shown by the white line in Fig. 4E. We
rst consider the relative distributions of the Amide I and the
biomarker features within the cell as indicated by the original
and deconvoluted 36 data (Fig. 5A). A comparison of the
proles from the Amide I chemical images from the original
and deconvoluted datasets shows that the deconvolution results
in a narrowing of the Amide distribution and a sharper edge at
the periphery of the cell. Several informative quantities will be
considered to evaluate the data. First, we will consider the
effective spacing between the Amide and biomarker distribu-
tions as measured from the distance between the peak values of
the Amide and biomarker proles as shown in Fig. 5. Next, to
quantify subcellular distances in this sample, we will consider,5614 | Analyst, 2013, 138, 5610–5618as a gure of merit, the distance between the peak value of the
integrated intensity to the point where it reaches its minimum
value (e.g., the peak-to-edge distances) for all of the proles
shown in Fig. 5. Lastly, to explore the relationship between error
propagation and spatial oversampling, we will discuss a simple
error analysis of the conclusions drawn on the Amide and
biomarker distributions.
We rst evaluate the relative displacements between the
Amide and biomarker signatures in the 36 and 74 datasets.
In Fig. 5A, both the original and deconvoluted data sets show
that the distance between the maximum values of the Amide
and biomarker signals is 2 pixels, or 2.2 mm given the effective
geometric pixel size at the sample plane for the 36 objective.
The same quantity for the 74 objective in Fig. 5B is exactly
3 pixels, corresponding to an effective geometric distance of
1.62 mm at the sample plane. This discrepancy between the 2
objectives is a direct result of the coarser sampling of the 36
objective. While the difference between the two values is onlyThis journal is ª The Royal Society of Chemistry 2013
Fig. 5 Line profiles through chemical images of the labelled cell shown in Fig. 4.
(A) Original and deconvoluted line profiles of the Amide and biomarker chemical
images shown in Fig. 4E–H. The profiles all come from the location indicated by
the white line in Fig. 4E. The displacement between the Amide and biomarker
signatures is measured to be 2.2 mm. (B) Original and deconvoluted line profiles of
the Amide and biomarker chemical images shown in Fig. 4A–D. The profiles all
come from the location indicated by the white line in Fig. 4A. The displacement
between the Amide and biomarker signatures is measured to be 1.62 mm.
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View Article Online0.58 mm, this difference is a signicant deviation of 35.8% from
the Amide/biomarker separation measured between the 74
objective and corresponds to, nearly identically, the effective
geometric size of one pixel using the 74 objective geometry
(0.54 mm). Thus, these data indicate that sufficient spatial
oversampling is critical in applications such as subcellular
microscopy of biological specimens.
We now consider the peak-to-edge distances in the proles
shown in Fig. 5 to evaluate the change between raw and
deconvoluted data for the two objectives. These distances for
the Amide I and biomarker signatures before and aer decon-
volution are summarized in Table 1. We begin with Amide
proles derived from the 36 objective (Fig. 5A); the distance
from the centre of the cell (the point of highest intensity in the
Amide prole) to the bottom edge of the cell (where the intensity
prole approaches its minimum value) is 7.8 mm in the original
data set and 6.4 mm in the deconvoluted dataset, indicating aTable 1 Changes in Amide and biomarker distribution for both objectives followi
Amide I peak-to-edge intensity
Objective Orig. (mm) Deconv. (mm) % Differe
36 7.8 6.4 18.0
74 8.7 6.6 24.0
This journal is ª The Royal Society of Chemistry 2013decrease of approximately 18% in the peak-to-edge spatial
distribution of the Amide. In the case of the biomarker, the
distance from the point of highest intensity of the biomarker to
the bottom edge of the cell where the biomarker signal drops to
zero changes from 10 mm in the original intensity prole
to 7.7 mm in the deconvoluted prole. This corresponds to a
decrease of 23% in the spatial distribution of the biomarker
following the application of deconvolution. For the case of the
74 objective, shown in Fig. 4B, a similar trend showing a
narrowing of the Amide and biomarker distributions is
observed following deconvolution. In this case, the Amide peak-
to-edge distance decreases from 8.7 mm in the original data to
6.55 mm in the deconvoluted data, corresponding to a change of
24%. Similarly, the peak-to-edge distance of the biomarker
signature decreases from 10.8 mm in the raw data to 8.1 mm in
the deconvoluted data, a change of 25%. These data give a direct
demonstration of the impact of spatial oversampling on the
effectiveness of deconvolution; the decrease in the effective
distribution of the biomarker and Amide signatures shows a
greater improvement for the case of the 74 oversampling than
that of the 36. For example, the change in peak-to-edge
distance of the Amide I and biomarker distributions following
deconvolution are 18% and 23%, respectively, for the 36
geometry. The same values for the 74 geometry are 24% and
25%; as before, these data indicate that the application of
deconvolution has a greater impact in the case of sufficiently
oversampled data. The relatively similar improvements between
the Amide I and biomarker signatures in the 74 geometry
upon deconvolution (24% and 25%) are consistent with the very
similar wavelengths that the biomarker and Amide absorptions
occur. With twice the pixel spacing of the 74 geometry, the
36 geometry has a measurement uncertainty that is 0.56 mm
greater than that of the 74 geometry. This uncertainty, though
small, can have a large impact on the assessment of distances
and overall image detail when performing microscopy at the
diffraction limit. This uncertainty is likely accountable for the
comparatively large discrepancy in the changes in the peak to
edge distances of the Amide I and biomarker distributions
following deconvolution (18% and 23%, respectively).
We now discuss this measurement uncertainty in more
detail. Consider rst the measurement of the change in peak to
edge distance in the Amide I distribution in the cell following
deconvolution (decrease from 7.8 mm to 6.4 mm in the 36 data,
Table 1). A measurement error of 1.1 mm in the peak to edge
distances in the original and deconvoluted data will give a
contribution of 4% toward the measurement error of the
percent change in this distance, giving an error of 18  18%.
Similarly, the error in the peak to edge measurement of theng deconvolution
Biomarker peak-to-edge intensity
nce Orig. (mm) Deconv. (mm) % Difference
10.0 7.7 23.0
10.8 8.1 25.0
Analyst, 2013, 138, 5610–5618 | 5615
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View Article Onlinebiomarker in the 36 data is 23  14%. The corresponding
errors for the 74 data given an uncertainty of 0.54 mm are
24  8% and 25  6% for the Amide and biomarker changes,
respectively. These data show that spatial oversampling has an
important, measurable effect on both overall spatial resolution
as well as measurement error, and underline the critical
importance of spatial oversampling when performing diffrac-
tion-limited spectromicroscopy.3.4 Impacts of spectral pre-processing of spectrochemical
dataset
To further explore the effect of data processing methods on the
spectral quality of the FTIR imaging data of the MBA-MD-231
cell incubated with 1, algorithms for PCA noise reduction and
RMie scattering correction have been applied. The results of
RMie scattering corrections for the PCA noise reduced hyper-
spectral cube of data of the MBA-MD-231 cell incubated with 1
are shown in Fig. 6A. To compare the spectral improvements
due to PCA noise reduction and RMieS algorithms, individual
FTIR spectra extracted from identical pixels in the respective
hyperspectral cubes (see dashed black lines in Fig. 2B) are
shown in Fig. 3A and 6A, respectively. When comparing these
stacks of spectra, the corrected data (Fig. 6A) contain lower
noise and have no baseline uctuations. Fig. 6B depicts the
stack of data with a portion of the spectral range and an
enlarged absorption scale. Thus, further enhancement is
observed in the absorption region (2100–1800 cm1) of 1 for the
corrected data in contrast to the raw FTIR spectra (Fig. 3B). The
well-dened absorption bands that are indicative of the
biomarker can be much more clearly evaluated in the corrected
data in Fig. 6B. These results demonstrate the effect of applying
the PCA noise reduction followed by RMie scattering correction
algorithms, improving the quality of the spectral data and the
absorption band-specic infrared images.Fig. 6 Stacks of extracted single FTIR spectra (spaced 2.2 micrometers apart
from one another), along the dashed line indicated in the images in Fig. 2B of the
PCA and RMie scatter-corrected data of the breast cancer cell incubated with 1 in
the wavenumber range 3750–1000 cm1 (A) and 2100–1800 cm1 (B).
5616 | Analyst, 2013, 138, 5610–56183.5 Impacts of combining spectral pre-processing and
spatial deconvolution of spectrochemical datasets
Since both the spatial and spectral corrections described in the
previous sections impact the spatial contrast, it is important to
explore the impact of combining these analytical approaches
that are performed on individual frequency dependent images
and on single pixel spectra. Thus, Fig. 7 shows a series of images
of the biomarker distribution (generated from the A1 band) aer
applying various corrections. The images in the rst column are
derived from the original data, before (top) and aer (middle)
deconvolution. The images in the second column are obtained
from PCA corrected data, before (top) and aer (middle)
deconvolution. The last column contains images generated by
applying both PCA correction followed by RMie scattering
correction algorithms. The nal row of gures shows the over-
lapping distributions of the original or pre-processed (blue) and
deconvoluted biomarker A1 (red) images to demonstrate the
impacts on spatial contrast. In Fig. 8, spectra from the same
pixel in all 6 original, pre-processed and deconvoluted data sets
are shown. The location from which the spectra are extracted
are indicated by the cross in Fig. 7B. The plots correspond to the
similar columns in Fig. 7. Spectra plotted in red are original or
pre-processed results, and blue are aer deconvolution has
been implemented. There are several conclusions about data
analysis that can be drawn from Fig. 7 and 8. First note that theFig. 7 Effect of spectral pre-processing on deconvoluted chemical images of the
localization of 1 (A1 mode). The top (A–C) row indicates original data with or
without pre-processing. The middle row (D–F) shows the results of deconvolution
on the corresponding datasets in the top row. The bottom row (G–I) shows red/
blue overlays of the previous two rows to demonstrate the impact of deconvo-
lution; original data is displayed as red and deconvoluted data as blue. The
columns are aligned such that the left column (A, D, and G) has no spectral pre-
processing, the middle column (B, E, and H) has been treated with PCA noise-
reduction, and the right column (C, F, and I) has been treated with PCA noise-
reduction followed by RMie scatter-correction.
This journal is ª The Royal Society of Chemistry 2013
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View Article Onlinebiomarker spectral signal is weak; thus, the signal to noise ratio
is small compared to strong absorbers such as the Amide I
absorption band. The results in the le-hand most column,
showing the original and deconvoluted results of data with no
spectral pre-processing, show that applying deconvolution to
data with severe noise emphasizes both spectral and spatial
features associated with low SNR due to the fact that noise
becomes effectively blurred by Fourier Filtering. In addition,
deconvolution can also enhance scattering contributions (more
severe in this case than in the data in Fig. 4 and 5), which are
indistinguishable from actual absorbance, resulting in more
severe baselines (blue spectra in Fig. 8A). These anomalousFig. 8 Original (red) and deconvoluted (blue) spectra from the datasets in Fig. 7.
Spectra are extracted from the pixel indicated by the cross in Fig. 7B. (A) shows the
results for spectra from Fig. 7A and D (no pre-processing, deconvolution applied
to as-measured data). (B) shows the results for spectra from Fig. 7B and E (PCA
noise-correction applied prior to deconvolution) and (C) shows the results for
spectra from Fig. 7C and F (PCA noise-correction and RMie scatter-correction
applied prior to deconvolution). The insets show the spectral region from 1800–
2300 cm1 to illustrate the importance of the corrections for the weak biomarker
signatures.
This journal is ª The Royal Society of Chemistry 2013baselines inevitably effect the quality of the resulting data and
the potential of deconvolution to enhance spatial resolution
and contrast. PCA-noise reduction, shown in Fig. 8C and F,
improves the spectral SNR and contrast in the images; however,
the deconvolution still enhances the scattering baseline.
Finally, applying the RMie scattering correction to the PCA
corrected data allows for much greater improvement in the
deconvolution process. First the images show a larger contrast
difference between the before and aer deconvolution; the nal
blue/red overlapped image indicates a much narrower spatial
distribution of the biomarker signature following deconvolu-
tion. Also, the baseline artefacts are clearly reduced (spectra in
Fig. 8C), and not enhanced with the deconvolution step.
These results demonstrate the effect of applying the PCA
noise reduction followed by RMie scattering correction algo-
rithms and spatial deconvolution, in a sequence with decon-
volution applied last, all improve the quality of the spectral data
and the absorption band specic, infrared images.4 Conclusions
Synchrotron based wideeld FTIR microspectroscopy studies
the imaging capabilities of different objectives with different
demonstrate impact of NA, spatial oversampling and PSF
deconvolution on spatial resolution. Measurements of incu-
bated MDA-MB-231 breast cancer cells demonstrate the ability
to create chemically specic images with high spatial contrast
and detect a low concentration exogenous metal-CO derivative 1
with a weak infrared signature at the single cell level. Images
from distinct functional groups show that 1 is partly overlaid
with a region rich in Amide and phosphate absorptions, which
is consistent with previous correlative infrared and lumines-
cence studies where we demonstrated 1 had a perinuclear
distribution attributed to the Golgi apparatus.19 Different
magnication and spatial oversampling conditions provide
direct comparisons between these optical choices. The original
data, which is rapidly collected with two different objectives,
has only slightly poorer spatial resolution to reported values for
data collected with raster-scanned, confocal optics with similar
NA. Nevertheless, in both cases, PSF deconvolution can be
applied to the data to remove instrumental broadening and
improve the spatial resolution to the reported values for
confocal optics with similar NA, and simultaneously improve
spectral purity of the hyperspectral cube. Spatial oversampling
is also critical for achieving optimum spatial resolution; our
results demonstrate that high spatial oversampling coupled
with large NA promotes greater impact in the results of
deconvolution and lower measurement uncertainty. Applying
spatial deconvolution to hyperspectral cubes has been
successful, improving the spatial contrast of the images and
SNR of the spectra. In addition, spectral pre-processing such as
PCA-based noise reduction and RMie scattering corrections
were applied to improve the SNR and remove the phenomenon
of resonant Mie scattering in the data sets, respectively. These
improvements were demonstrated by comparing the FTIR
images and the extracted single-pixel spectra before and aer
the correction procedures.Analyst, 2013, 138, 5610–5618 | 5617
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